McElhaney v. Eli Lilly & Co.

93 F.R.D. 875, 34 Fed. R. Serv. 2d 1017, 1982 U.S. Dist. LEXIS 11732
CourtDistrict Court, D. South Dakota
DecidedApril 8, 1982
DocketNo. 80-3069
StatusPublished
Cited by23 cases

This text of 93 F.R.D. 875 (McElhaney v. Eli Lilly & Co.) is published on Counsel Stack Legal Research, covering District Court, D. South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McElhaney v. Eli Lilly & Co., 93 F.R.D. 875, 34 Fed. R. Serv. 2d 1017, 1982 U.S. Dist. LEXIS 11732 (D.S.D. 1982).

Opinion

MEMORANDUM OPINION

DONALD J. PORTER, District Judge.

CASE SUMMARY

The plaintiff in this pharmaceutical products liability action has moved for cer[877]*877tification of a plaintiff class pursuant to Rule 23 of the Federal Rules of Civil Procedure. The proposed class consists of all persons exposed to diethylstilbestrol (DES) in útero who presently reside in South Dakota. For the reasons which follow, plaintiff’s motion for class certification is denied.

FACTUAL BACKGROUND

Plaintiff Patricia McElhaney alleges that she has developed a pre-cancerous condition as a result of her prenatal exposure to diethylstilbestrol (DES), a synthetic estrogen taken by her mother in 1949. In the late 1940s and early 1950s, pharmaceutical manufacturers promoted DES for use by pregnant women to prevent loss of the fetus by spontaneous abortion. Plaintiff alleges that her mother had ingested DES for several months prior to plaintiff’s birth on December 31,1949, the drug having been prescribed to prevent a possible miscarriage.

Plaintiff seeks to represent a class composed of “all male and female young people residing in South Dakota who are similarly situated in that they have been exposed to DES as unborn children.” Complaint, II 4. Plaintiff is unable to identify the manufacturer or manufacturers of the DES ingested by her mother. The complaint names eight drug companies as defendants, and alleges their joint and individual liability in the marketing, dispensing, and promoting of DES. For herself, plaintiff sues for both actual and punitive damages. For class members, plaintiff seeks injunctive relief requiring defendants to conduct a publicity campaign on DES, and to establish clinics in South Dakota which would provide free medical examination to class members. Plaintiff asserts various causes of actions: Negligence, strict liability, battery, breach of warranty and violation of the Federal Food, Drug and Cosmetic Act.

DISCUSSION

In order to maintain an action as a> class action, the parties seeking class status have the burden of showing that the four prerequisites to Rule 23(a) are satisfied, namely: (1) the class is so numerous that joinder of all members is impracticable, (2) there are questions of law or fact common to the class, (3) the claims or defenses of the representative parties are typical of the claims or defenses of the class, and (4) the representative parties will thoroughly and adequately protect the interests of the class. The parties seeking class certification must also prove' that the proposed class action falls within one of the alternative requirements of Rule 23(b). Rule 23(a) includes two additional requirements by implication, namely that a class must exist, and that the representative parties must be members of such class. 3B Moore’s Federal Practice H 23.04 (2d Ed. 1978).

A. EXISTENCE OF CLASS.

Prior to a consideration of the criteria established by Rule 23, the Court must determine whether a class exists, and is capable of legal definition. Vietnam Veterans Against the War v. Benecke, 63 F.R.D. 675, 679 (W.D.Mo.1974). Plaintiff seeks to represent “all male and female young people residing in South Dakota who are similarly situated and in that they have been exposed to DES as unborn children.” Complaint, H 4. Although plaintiff alleges that she is suffering from DES-related injuries, there appears to be no requirement that any class member has sustained any injury or damage. Rather, the plaintiff alleges that class members may already have injuries and that class members suffer a threat of grave harm and loss. See Complaint, HH 32, 68 (emphasis added). It is highly likely that a substantial number of persons in the pro-„ posed class would not know whether they were members of such a class, since they do not suffer from any (apparent injury and do not know whether their mothers took DES. while pregnant. Nonetheless, plaintiff’s proposed class includes “young people who have been exposed to DES before' birth, and .who may or may not kno.w-that fact . . . .” Complaint, II 66. ~- —

The class definition does not require that the class members’ births have occurred in [878]*878South Dakota.1 Thus, it is probable that class members’ mothers are scattered over the entire United States. Even assuming such persons could be located, many may be deceased and their medical records destroyedX'Coñsequently, a large number of persons included in plaintiff’s proposed class will never be able to determine whether they__were exposed to DES. Further, the composition of the proposed class is constantly changing, as unknown persons move into and from South Dakota.

The definition of a class cannot be so broad as to include individuals who are without standing to maintain the action on their own behalf. Each class member must have standing to bring the suit in his own right. See Kister v. Ohio Bd. of Regents, 365 F.Supp. 27 (S.D.Ohio, 1973), aff’d, 414 U.S. 1117, 94 S.Ct. 855, 38 L.Ed.2d 747 (1974); Lamb v. Hamblin, 57 F.R.D. 58 (D.Minn.1972); and Thomas v. Clarke, 54 F.R.D. 245 (D.Minn.1971). In the case at bar, plaintiff does not allege that any member of the class, other than herself, has sustained injury or damage. Since many individuals included in the purported class have sustained no injury in fact, they would lack standing to bring suit in their own right.

The factors discussed supra present formidable barriers to the very existence of a “class”. The proposed class, in this Court’s view, is not adequately defined, nor are its members readily identifiable. The failure to establish the existence of a class, alone, is enough to deny class certification. The Court, however, will also discuss the reasons under the criteria of Rule 23 for denying class certification.

B. TYPICALITY.

Rule 23(a)(3) requires that in a class action “the claims or defenses of the representative parties [be] typical of the claims or defenses of the class.” The typicality requirement guarantees that a representative’s interest will be co-extensive with the interests of potential class members. Koehler v. Ogilvie, 53 F.R.D. 98, 100 (N.D.Ill.1971), aff’d 405 U.S. 906, 92 S.Ct. 938, 30 L.Ed.2d 777 (1972). In addition, the requirement ensures that no claim of a class member, or significant aspects of such claim, will go unrepresented by representative plaintiffs. Sommers v. Abraham Lincoln Federal Savings & Loan Assoc., 66 F.R.D. 581 (E.D.Pa.1975). In short, in the course of proving her own claim, plaintiff must also prove the claims of the other members of the class. The claims and defenses of the class representative “would not be typical if it would require substantially more or less proof than required for the other members of the class.” Amswiss Int. Corp. v. Heublein, Inc., 69 F.R.D. 663, 667 (N.D.Ga.1975).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jackson v. Unocal Corp.
262 P.3d 874 (Supreme Court of Colorado, 2011)
Saltzman v. Pella Corp.
257 F.R.D. 471 (N.D. Illinois, 2009)
In Re Tobacco II Cases
207 P.3d 20 (California Supreme Court, 2009)
In re Teflon Products Liability Litigation
254 F.R.D. 354 (S.D. Iowa, 2008)
McAdams v. Monier, Inc.
60 Cal. Rptr. 3d 111 (California Court of Appeal, 2007)
In Re the Cadillac V8-6-4 Class Action
461 A.2d 736 (Supreme Court of New Jersey, 2004)
O'Neill v. Gourmet Systems of Minnesota, Inc.
219 F.R.D. 445 (W.D. Wisconsin, 2002)
Dhamer v. Bristol-Myers Squibb Co.
183 F.R.D. 520 (N.D. Illinois, 1998)
Sun Coast Resources, Inc. v. Cooper
967 S.W.2d 525 (Court of Appeals of Texas, 1998)
In Re American Medical Systems, Inc. Pfizer, Inc.
75 F.3d 1069 (Sixth Circuit, 1996)
DeSario v. Industrial Excess Landfill, Inc.
587 N.E.2d 454 (Ohio Court of Appeals, 1991)
Johnson v. Gross
125 F.R.D. 169 (W.D. Oklahoma, 1989)
Jolly v. Eli Lilly & Co.
751 P.2d 923 (California Supreme Court, 1988)
Arnold v. Postmaster General
667 F. Supp. 6 (District of Columbia, 1987)
Collins v. Safeway Stores, Inc.
187 Cal. App. 3d 62 (California Court of Appeal, 1986)
In re Tetracycline Cases
107 F.R.D. 719 (W.D. Missouri, 1985)
Walsh v. Ford Motor Co.
106 F.R.D. 378 (District of Columbia, 1985)
Cleveland Board of Education v. Armstrong World Industries, Inc.
476 N.E.2d 397 (Cuyahoga County Common Pleas Court, 1985)
Slaughter v. Levine
598 F. Supp. 1035 (D. Minnesota, 1984)
Van-S-Aviation v. Piper Aircraft Corp.
101 F.R.D. 759 (W.D. Missouri, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
93 F.R.D. 875, 34 Fed. R. Serv. 2d 1017, 1982 U.S. Dist. LEXIS 11732, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcelhaney-v-eli-lilly-co-sdd-1982.